Cargando…
The synergistic effects of Apatinib combined with cytotoxic chemotherapeutic agents on gastric cancer cells and in a fluorescence imaging gastric cancer xenograft model
INTRODUCTION: Methylsulfonic apatinib (hereinafter referred to as Apatinib) is a small-molecule angiogenesis inhibitor highly and selectively targeted to vascular endothelial growth factor receptor-2. At present, a series of basic and clinical studies have confirmed that Apatinib mono-therapy can in...
Autores principales: | Feng, Jiuhuan, Qin, Shukui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975614/ https://www.ncbi.nlm.nih.gov/pubmed/29872316 http://dx.doi.org/10.2147/OTT.S159935 |
Ejemplares similares
-
Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
por: Qiu, Zhi-Yuan, et al.
Publicado: (2021) -
Therapeutic effect of apatinib on overall survival is mediated by prolonged progression-free survival in advanced gastric cancer patients
por: Huang, Lihong, et al.
Publicado: (2016) -
Combined aspirin and apatinib treatment suppresses gastric cancer cell proliferation
por: Zhang, Wei, et al.
Publicado: (2017) -
Comparison of the synergistic anticancer activity of AlPcS(4) photodynamic therapy in combination with different low-dose chemotherapeutic agents on gastric cancer cells
por: Xin, Jing, et al.
Publicado: (2018) -
Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model
por: Jiang, Jiahua, et al.
Publicado: (2015)